Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Dexcom (DXCM) Other Gross PP&E Adjustments (2016 - 2026)

Dexcom has reported Other Gross PP&E Adjustments over the past 17 years, most recently at $2.4 billion for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 17.82% to $2.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Mar 2026, up 17.82% year-over-year, with the annual reading at $2.3 billion for FY2025, 20.06% up from the prior year.
  • Other Gross PP&E Adjustments was $2.4 billion for Q1 2026 at Dexcom, up from $2.3 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $2.4 billion in Q1 2026 and troughed at $1.0 billion in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $1.6 billion (2024), against an average of $1.7 billion.
  • Year-over-year, Other Gross PP&E Adjustments skyrocketed 56.7% in 2022 and then rose 14.2% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.3 billion in 2022, then rose by 15.29% to $1.5 billion in 2023, then rose by 26.82% to $1.9 billion in 2024, then rose by 20.06% to $2.3 billion in 2025, then rose by 3.09% to $2.4 billion in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Other Gross PP&E Adjustments are $2.4 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.2 billion (Q3 2025).